Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • DG’s Column
    • Statements
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Videos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Inventing Medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Climate change Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigilance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigilance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos in Action Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Global Policy Principles on Digital Health Health technology assessment IP Technology Transfer Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health COVID-19 Diabetes Ebola Falsified medicines HIV/AIDS Influenza Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Pandemic Preparedness Public health implications of the implementation of the Nagoya Protocol Rare diseases Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccination confidence Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis

spotlight

Universal Health Coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • Publications
  • >
  • Applying Lessons Learned from COVID-19 to Create a Healthier, Safer, More Equitable World

Applying Lessons Learned from COVID-19 to Create a Healthier, Safer, More Equitable World

Published on: 22 May 2022

Downloads

» IFPMA_COVID-19_Pandemic_Lessons_Learned_May_2022

Resources

Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response
News Releases

News Releases

Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response

10 Leçons Tirées de la Pandémie de la COVID-19 Pour Créer un Monde en Meilleur Santé et Plus Équitable
Publications

Publications

10 Leçons Tirées de la Pandémie de la COVID-19 Pour Créer un Monde en Meilleur Santé et Plus Équitable

Three priorities to urgently increase access to COVID-19 vaccines
News Releases

News Releases

Three priorities to urgently increase access to COVID-19 vaccines

Three priorities to urgently increase access to COVID-19 vaccines (video)
Videos

Videos

Three priorities to urgently increase access to COVID-19 vaccines (video)

Five steps to urgently advance COVID-19 vaccine equity
News Releases

News Releases

Five steps to urgently advance COVID-19 vaccine equity

Five steps to urgently advance COVID-19 vaccine equity (Video)
Videos

Videos

Five steps to urgently advance COVID-19 vaccine equity (Video)

Global Biopharma CEO COVID-19 Media Briefing – 13 April 2022 (Video)
Videos

Videos

Global Biopharma CEO COVID-19 Media Briefing – 13 April 2022 (Video)

Related Blog Entries

The Biopharmaceutical Industry’s Three Priorities to Urgently Increase COVID-19 Vaccine Access

The Biopharmaceutical Industry’s Three Priorities to Urgently Increase COVID-19 Vaccine Access

The global biopharmaceutical industry’s united front against COVID-19

The global biopharmaceutical industry’s united front against COVID-19

COVID-19 vaccines: Meeting the world’s need (Step #2)

COVID-19 vaccines: Meeting the world’s need (Step #2)

Related Links

IFPMA COVID-19 Innovation Timeline

Related Topics

Pandemic Preparedness
COVID-19
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top